Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-24
    E.g., 2018-09-24

Articles

Pages

7735 items
10:38 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

uBiome moving into therapeutics with $83M series C

Microbiome tech and diagnostic company uBiome Inc. (San Francisco, Calif.) raised $83 million in a series C round led by OS Fund to expand into drug research and development using its patented microbiome assets. Also...
10:37 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

DePinho's STAT3 company Tvardi raises $9M series A

Tvardi Therapeutics Inc. (Houston, Texas) raised $9 million on Sept. 20 in a series A round from Alexandria Venture Investments and other undisclosed institutional and private investors. Tvardi is developing inhibitors of signal transducer and activator...
9:33 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Biodesy raises $20M in series C, appoints new CEO

Biodesy Inc. (South San Francisco, Calif.) raised $20 million Sept. 10 in a series C round led by new investor Alexandria Venture Investments. Existing investors 5AM Ventures, Pfizer Ventures and Roche Venture Fund also participated...
9:32 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Principia jumps after $106.3M IPO

Principia Biopharma Inc. (NASDAQ:PRNB) leaped $15.65 (92%) to $32.65 on Sept. 14, its first day of trading, after raising $106.3 million late Sept. 13 through the sale of 6.3 million shares at $17 in an...
9:31 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Gene therapy company Horama closes series B at €22.5M

Horama S.A. (Paris, France) closed its series B round at €22.5 million ($26.3 million) with an additional €3.5 million ($4.1 million) investment from V-Bio Ventures. Last year, the company raised €19 million ($22.2 million) in...
9:30 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

G1 prices $180M follow-on

G1 Therapeutics Inc. (NASDAQ:GTHX) raised $180 million in a follow-on that priced after hours on Sept. 18. G1 sold 3 million shares at $60 in an offering underwritten by J. P. Morgan, Cowen, Needham, Wedbush, BTIG...
9:30 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

argenx prices $300M follow-on

argenx S.E. (Euronext:ARGX; NASDAQ:ARGX) raised $300.6 million in a follow-on that priced after hours on Sept. 18. argenx sold 3.5 million ADSs at $86.50, an 8% discount to its NASDAQ close of $93.77 on Sept. 17,...
9:29 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Ahead of Phase III mucositis study, Galera raises $150M

Galera Therapeutics Inc. (Malvern, Pa.) raised a combined $150 million in a $70 million series C round and $80 million royalty deal led by new investor Clarus. The fund-raising comes ahead of Galera's planned Phase...
12:16 PM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Hua raises $110.5M in HK IPO, trades flat on first day

Hua Medicine Ltd. (HKSE:2552) shares ended the day unchanged at HK$8.28 in the company's first day of trading Sept. 14. The diabetes play raised HK$867 million ($110.5 million) in an IPO through the sale of...
12:16 PM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Completed Offerings

Atreca’s $125M round paves way for first immunotherapy into clinic

Atreca Inc. (Redwood City, Calif.) raised $125 million in a series C round led by an undisclosed U.S.-based healthcare fund, clearing the way for the company to move its first cancer immunotherapy into the clinic. Fellow...

Pages